Shareholding disclosure

Santhera Pharmaceuticals Holding AG

Collectively declared rate

61.68%

Threshold

Crossed upwards

Timeline

Published

02.11.2006

Transaction

—

Voting rights breakdown

Voting rights acquired61.68%

Voting rights sold0%

Below threshold0%

Declared beneficial owners · 47

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

T4411D4203

Beneficial owner

NGN BioMed I GP, L.P

Declared address

NGN BioMed I GP, L.P., New York, NY 10017

Stimmrechtsanteil berechnet auf der Grundlage des Aktienkapitals nach Ausübung des Greenshoes; 02.11.2006; Kotierungsprospekt

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG02.11.2006T4411D4203

Disclosure summary

NGN BioMed I GP, L.P disclosed a holding in Santhera Pharmaceuticals Holding AG on the acquisition side, published by SIX Exchange Regulation on 02.11.2006, at 61.68% of voting rights. The filing groups 47 beneficial owners declared together. Notice category: Group of shareholders.

Disclosed position

Collectively declared rate

47 people

61.68%

Voting rights acquired

Voting rights acquired61.68%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Declared beneficial owners · 47 people

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Disclosure detail

NGN BioMed I GP, L.P disclosed a holding in Santhera Pharmaceuticals Holding AG, published on 02.11.2006.

Publication date02.11.2006

Issuing companySanthera Pharmaceuticals Holding AG

Beneficial ownerNGN BioMed I GP, L.P

Declared addressNGN BioMed I GP, L.P., New York, NY 10017

CategoryGroup of shareholders

Voting rights acquired61.68%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDT4411D4203

Conditions

Stimmrechtsanteil berechnet auf der Grundlage des Aktienkapitals nach Ausübung des Greenshoes; 02.11.2006; Kotierungsprospekt

Source: SIX Exchange Regulation · Publication date: 02.11.2006

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open